Drawing for ENFORCER

USPTO serial 88461039

ENFORCER

Reviewed by CopyMark Law Group

Reg. 5981450Status 710
Filing date
Status date
Registration date
Feb 11, 2020
Examiner
MORENO, PAUL A
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ENFORCER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Keith Toms, Esq.

Keith Toms, Esq. McCarter & English, LLP265 Franklin StreetBoston, MA 02110United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; vaccine preparations; antibodies sold as an ingredient of pharmaceuticals for the treatment of treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies for use in the production of active ingredients of pharmaceuticals and vaccines; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosisSECTION 8 - CANCELLED—
042Research and development in the pharmaceutical and biotechnology fields; research and development of medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; providing medical and scientific research information in the field of pharmaceuticals; Research and development services in the field of antibodiesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 21, 2026C8..CANCELLED SEC. 8 (6-YR)—
Jul 31, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 31, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 31, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 31, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 31, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 31, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 11, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 17, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 17, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 17, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 17, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 17, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 1, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 24, 2024ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Feb 11, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 26, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 26, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 6, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 17, 2019FIXDELECTRONIC RECORD REVIEW COMPLETE—
Oct 11, 2019ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Oct 7, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 13, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 13, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 10, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Sep 3, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 3, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Sep 3, 2019CNSLSUSPENSION LETTER WRITTEN—
Aug 29, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 29, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 29, 2019ALIEASSIGNED TO LIE—
Aug 26, 2019DOCKASSIGNED TO EXAMINER—
Aug 21, 2019PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jun 19, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 8, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance